Which Healthcare ETF Is the Better Buy: VanEck’s Pharma Fund PPH or iShares’ Biotech Fund IBB?
The article compares two healthcare ETFs: VanEck Pharmaceutical ETF (PPH) and iShares Biotechnology ETF (IBB). PPH focuses on 26 large, established drugmakers with lower volatility, higher dividend yield (1.8%), and lower expense ratio (0.36%). IBB offers broader diversification with 243 holdings but higher volatility and minimal dividend yield (0.2%). The author recommends PPH for long-term investors seeking stability and income, particularly given the major pharmaceutical companies' acquisition activity in biotech.
